These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34756525)

  • 1. Cost-effectiveness analysis of pharmacist interventions in patients with heart failure in Thailand.
    Arunmanakul P; Chaiyakunapruk N; Phrommintikul A; Ruengorn C; Permsuwan U
    J Am Pharm Assoc (2003); 2022; 62(1):71-78. PubMed ID: 34756525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-Effectiveness Analysis of Sacubitril-Valsartan Compared with Enalapril in Patients with Heart Failure with Reduced Ejection Fraction in Thailand.
    Krittayaphong R; Permsuwan U
    Am J Cardiovasc Drugs; 2018 Oct; 18(5):405-413. PubMed ID: 29926351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of pharmacist-participated warfarin therapy management in Thailand.
    Saokaew S; Permsuwan U; Chaiyakunapruk N; Nathisuwan S; Sukonthasarn A; Jeanpeerapong N
    Thromb Res; 2013 Oct; 132(4):437-43. PubMed ID: 24041634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-utility analysis of add-on dapagliflozin treatment in heart failure with reduced ejection fraction.
    Krittayaphong R; Permsuwan U
    Int J Cardiol; 2021 Jan; 322():183-190. PubMed ID: 32800910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-Utility Analysis of Transcatheter Aortic Valve Implantation versus Surgery in High-Risk Severe Aortic Stenosis Patients in Thailand.
    Permsuwan U; Yoodee V; Buddhari W; Wongpraparut N; Thonghong T; Cheewatanakornkul S; Meemook K; Sakiyalak P; Duangpakdee P; Yadee J
    Clinicoecon Outcomes Res; 2022; 14():487-498. PubMed ID: 35909499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-Effectiveness of Cardiac Resynchronization Therapy in Patients with Heart Failure in Thailand.
    Permsuwan U; Phrommintikul A; Silavanich V
    Clinicoecon Outcomes Res; 2020; 12():579-588. PubMed ID: 33116697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-Effectiveness Analysis of the Adjunctive Therapy of Ivabradine for the Treatment of Heart Failure with Reduced Ejection Fraction.
    Krittayaphong R; Yadee J; Permsuwan U
    Clinicoecon Outcomes Res; 2019; 11():767-777. PubMed ID: 31824183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-utility analysis of transcatheter aortic valve implantation versus surgery in severe aortic stenosis patients with intermediate surgical risk in Thailand.
    Permsuwan U; Yoodee V; Buddhari W; Wongpraparut N; Thonghong T; Cheewatanakornkul S; Meemook K; Sakiyalak P; Duangpakdee P; Yadee J
    J Geriatr Cardiol; 2022 Nov; 19(11):822-832. PubMed ID: 36561052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analysis of pharmacogenetic-guided warfarin dosing in Thailand.
    Chong HY; Saokaew S; Dumrongprat K; Permsuwan U; Wu DB; Sritara P; Chaiyakunapruk N
    Thromb Res; 2014 Dec; 134(6):1278-84. PubMed ID: 25456732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vericiguat for the Treatment of Heart Failure with Reduced Ejection Fraction Following a Worsening Heart Failure Event: A Cost-Effectiveness Analysis from the Perspective of Chinese Healthcare Providers.
    Yu X; Hao Y; Zhu Z; Zhang W; Liu B; Ma M; Zhang X; Wei N; Wang J; Liu F
    Clin Drug Investig; 2023 Apr; 43(4):241-250. PubMed ID: 36929485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-utility analysis of sutureless and rapid deployment versus conventional aortic valve replacement in patients with moderate to severe aortic stenosis in Thailand.
    Permsuwan U; Singhatanadgige S; Boonpipattanapong K; Slisatkorn W; Chartrungsan A; Nitayavardhana P; Luangthong N; Porapakkham P; Yadee J
    PLoS One; 2024; 19(1):e0296875. PubMed ID: 38241391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-Utility Analysis of First-Line Pemetrexed Plus Cisplatin in Non-Small Cell Lung Cancer in Thailand.
    Permsuwan U; Thongprasert S; Sirichanchuen B
    Value Health Reg Issues; 2020 May; 21():9-16. PubMed ID: 31634796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An updated cost-effectiveness analysis of pneumococcal conjugate vaccine among children in Thailand.
    Dilokthornsakul P; Kengkla K; Saokaew S; Permsuwan U; Techasaensiri C; Chotpitayasunondh T; Chaiyakunapruk N
    Vaccine; 2019 Jul; 37(32):4551-4560. PubMed ID: 31280944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-Utility Analysis of Combination Empagliflozin and Standard Treatment Versus Standard Treatment Alone in Thai Heart Failure Patients with Reduced or Preserved Ejection Fraction.
    Krittayaphong R; Permsuwan U
    Am J Cardiovasc Drugs; 2022 Sep; 22(5):577-590. PubMed ID: 35796952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of sacubitril/valsartan versus enalapril in patients with heart failure and reduced ejection fraction.
    Liang L; Bin-Chia Wu D; Aziz MIA; Wong R; Sim D; Leong KTG; Wei YQ; Tan D; Ng K
    J Med Econ; 2018 Feb; 21(2):174-181. PubMed ID: 28959905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of a community pharmacist intervention in patients with depression: a randomized controlled trial (PRODEFAR Study).
    Rubio-Valera M; Bosmans J; Fernández A; Peñarrubia-María M; March M; Travé P; Bellón JA; Serrano-Blanco A
    PLoS One; 2013; 8(8):e70588. PubMed ID: 23950967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-utility analysis of an alcohol policy in Thailand: a case study of a random breath testing intervention.
    Vichitkunakorn P; Khampang R; Leelahavarong P; Nontarak J; Assanangkornchai S
    BMC Health Serv Res; 2024 Jun; 24(1):739. PubMed ID: 38886718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
    McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
    Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-Effectiveness Analysis of Pharmacist Adherence Interventions in People Living with HIV/AIDS in Pakistan.
    Ahmed A; Dujaili JA; Chuah LH; Hashmi FK; Le LKD; Chatha ZF; Khanal S; Awaisu A; Chaiyakunapruk N
    Healthcare (Basel); 2023 Sep; 11(17):. PubMed ID: 37685487
    [No Abstract]   [Full Text] [Related]  

  • 20. A cost-effectiveness analysis of national smoking cessation services among chronic obstructive pulmonary disease patients in Thailand.
    Prasitwarachot R; Thavorn K; Patikorn C; Wattanasirichaigoon S; Rungruanghiranya S; Thongphiew A; Chaiyakunapruk N
    J Med Econ; 2023; 26(1):1377-1385. PubMed ID: 37818930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.